NCT07629791 Effects of Augmented Reality (AR) and Transcranial Direct Current Stimulation (tDCS)
| NCT ID | NCT07629791 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 28 participants |
| Start Date | 2026-05-20 |
| Primary Completion | 2026-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 28 participants in total. It began in 2026-05-20 with a primary completion date of 2026-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this randomized controlled trial is to determine the effects of Augmented Reality (AR)-based balance training on improving balance and postural control in chronic stroke survivors and whether the addition of transcranial Direct Current Stimulation (tDCS) to AR training produces superior outcomes compared to AR training alone.
Eligibility Criteria
Inclusion Criteria: * Balance impairment confirmed by Berg Balance Scale (BBS) score 21-44. * Age between 18-90 years. * Mild or no spasticity in lower limb (MAS ≤ 2) * have sufficient cognition to follow the instructions provided by the therapists and the computer. Exclusion Criteria: * Individuals with implanted electronic devices (e.g., pacemakers), due to interaction risk with tDCS * Other medical or psychological conditions affecting participation (e.g., severe pain, epilepsy, pacemaker). * Patients with severe cognitive deficits or visual impairments
Contact & Investigator
Aaleen Fatima, MS-NMPT*
PRINCIPAL INVESTIGATOR
Riphah International Unversity
Frequently Asked Questions
Who can join the NCT07629791 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07629791 currently recruiting?
Yes, NCT07629791 is actively recruiting participants. Contact the research team at abrish.habib@riphah.edu.pk for enrollment information.
Where is the NCT07629791 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan.
Who is sponsoring the NCT07629791 clinical trial?
NCT07629791 is sponsored by Riphah International University. The principal investigator is Aaleen Fatima, MS-NMPT* at Riphah International Unversity. The trial plans to enroll 28 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.